Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dcce39a20bef16c3f04497659caba40f |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2863 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6849 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6803 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-40 |
filingDate |
2018-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57937a7dfc9334967c93474d21f85e0a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f75c0800b8975f37c915736e35c53c95 |
publicationDate |
2020-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-3675908-A1 |
titleOfInvention |
Anti-egfr antibody drug conjugates (adc) and uses thereof |
abstract |
The present invention relates to antibody-drug conjugates (ADCs) comprising a cytotoxic or cytostatic agent linked to an anti-EGFR antibody via a linker, compositions comprising ADCs, processes for preparing ADCs, and methods for treating cancer comprising administering ADCs to a subject suffering from cancer. The present invention relates to ADCs which bind specifically to EGFR, and in particular to human EGFR (hEGFR). The anti-EGFR antibody according to the invention comprises a S239C mutation in a heavy chain constant region, the numbering being in accordance with the Kabat numbering. |
priorityDate |
2017-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |